Measurement of hs-CRP is irrelevant to diagnose and stage endometriosis: prospective study of 834 patients
Other
OA: closed
CC0
⤵ 15 in-corpus citations
AI-generated summary
High-sensitivity C-reactive protein (hs-CRP) measurement is not relevant for diagnosing or staging endometriosis, as demonstrated in a prospective study of 834 patients.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
OBJECTIVE: The pathogenesis of endometriosis is associated with an inflammatory process. Here, we assessed if the levels of high-sensitivity C-reactive protein (hs-CRP) in serum could constitute an effective method for detecting systemic inflammation during endometriosis.
STUDY DESIGN: This was a prospective, laboratory-based study, which was carried out in a tertiary care university hospital. Patients with histologically proven endometriosis (n = 370) and unaffected women (n = 464) were enrolled from January 2005 through December 2009. We performed complete surgical excision of endometriotic lesions with pathological analysis. In addition, hs-CRP levels were determined through a particle-enhanced immunoturbidimetric method. The hs-CRP levels were measured in both controls and women with endometriosis according to the established surgical classifications of endometriosis: superficial peritoneal endometriosis, endometrioma, and deep infiltration endometriosis. Also, hs-CRP levels were evaluated according to hormonal treatment and menstrual cycle.
RESULTS: The hs-CRP serum levels did not statistically differ between women with endometriosis and controls (median in ng/mL [range]: 0.82 [0.04-42.89] vs 0.9 [0.03-43.73], respectively; P = .599). Moreover, subgroup analysis revealed no difference among superficial peritoneal endometriosis, endometrioma, deep infiltration endometriosis, and controls: 0.8 (0.15-13.35), 0.81 (0.04-38.82), 0.83 (0.09-42.89), and 0.9 (0.03-43.73), respectively; P = .872. Furthermore, no effect was observed regarding hormonal treatment or menstrual cycle.
CONCLUSION: Although endometriosis is an inflammatory disease, we failed to identify any systemic changes in hs-CRP serum levels. Therefore, hs-CRP analysis appears to be irrelevant to the diagnosis and staging of endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (36)
- Accuracy of magnetic resonance imaging and rectal endoscopic sonography for the prediction of location of deep pelvic endometriosis via openalex
- A high sensitivity assay is more accurate than a classical assay for the measurement of plasma CRP levels in endometriosis via openalex
- Consensus on current management of endometriosis via openalex
- Determinants of long-term clinically detected recurrence rates of deep, ovarian, and pelvic endometriosis via openalex
- Elevated levels of fibroblast growth factor-2 in serum from women with endometriosis via openalex
- Endometrial nerve fiber proliferation in "endometriosis" via openalex
- Endometriosis via openalex
- Impact of endometriosis on women's health: comparative historical data show that the earlier the onset, the more severe the disease via openalex
- Non-invasive diagnosis of endometriosis based on a combined analysis of six plasma biomarkers via openalex
- Ovarian endometrioma: severe pelvic pain is associated with deeply infiltrating endometriosis via openalex
- PAPP-A and osteoprotegerin, together with interleukin-8 and RANTES, are elevated in the peritoneal fluid of women with endometriosis via openalex
- Pathogenesis of endometriosis: the role of peritoneal fluid via openalex
- Peripheral biomarkers of endometriosis: a systematic review via openalex
- Preoperative work-up for patients with deeply infiltrating endometriosis: transvaginal ultrasonography must definitely be the first-line imaging examination via openalex
- Recommendations for the design of epidemiologic studies of endometriosis via openalex
- Relation between pain symptoms and the anatomic location of deep infiltrating endometriosis via openalex
- Serum and peritoneal interleukin-33 levels are elevated in deeply infiltrating endometriosis via openalex
- Serum levels of VEGF and TNF-alpha and their association with C-reactive protein in patients with endometriosis via openalex
- Surgery for bladder endometriosis: long-term results and concomitant management of associated posterior deep lesions via openalex
- Surgical treatment of deep endometriosis and risk of recurrence via openalex
- Surgical treatment of deep endometriosis and risk of recurrence via openalex
- Tailoring radicality in demolitive surgery for deeply infiltrating endometriosis via openalex
- W2100503022 via openalex
- W2147493587 via openalex
- W2148322270 via openalex
- W2134618546 via openalex
- W2040020872 via openalex
- W2028228566 via openalex
- W2161687223 via openalex
- W1990643218 via openalex
- W2477008945 via openalex
- W1986309799 via openalex
- W4243536911 via openalex
- W2154918506 via openalex
- W2142769519 via openalex
- W2109820701 via openalex
Cited by (16)
- Preserved large elastic arterial stiffness and impaired conduit artery endothelial function in patients with endometriosis receiving progestin therapy: A cross-sectional observational study 2026
- Diagnostic Clues for Women with Acute Surgical Abdomen Associated with Ruptured Endometrioma 2023
- Blood tests for prediction of deep endometriosis: A case-control study 2021
- Diagnostic Significance of Selected Serum Inflammatory Markers in Women with Advanced Endometriosis 2021
- The role of monocyte to high-density lipoprotein cholesterol ratio in prediction of increased systemic inflammation and the risk of cardiovascular disease in endometriosis 2021
- Novel diagnostic options for endometriosis - Based on the glycome and microbiome 2021
- Target identification and drug discovery by data-driven hypothesis and experimental validation in ovarian endometriosis 2021
- Endometriosis phenotypes are associated with specific serum metabolic profiles determined by proton-nuclear magnetic resonance 2020
- Plasma AXIN1 expression exhibit negative correlations with inflammatory biomarkers and is associated with gastrointestinal symptoms in endometriosis 2020
- Blood biomarkers for the non-invasive diagnosis of endometriosis 2016
- Role of the protein kinase BRAF in the pathogenesis of endometriosis 2016
- Panel of Autoimmune Markers for Noninvasive Diagnosis of Minimal-Mild Endometriosis 2016
- Strong Association Between Endometriosis and Symptomatic Leiomyomas 2016
- Preoperative assessment and diagnosis of endometriosis: are we any closer? 2015
- Inhibition of MAPK and VEGFR by Sorafenib Controls the Progression of Endometriosis 2015
- Targeting oxidative stress to treat endometriosis 2015
Source provenance
- europepmc
- last seen: 2026-10-14T06:08:39.101224+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:13:13.905685+00:00
License: CC0
· commercial use OK